- Title: Subtitle
- CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors
- Creators
- Courtney KaemmerShaikamjad UmesalmaChandra MaharjanJordan KohlmeyerEmily WilkersonRyan SheehyMariah LeidingerDavid MeyerholzSarah BellGideon ZambaPatrick BrehenyEdmund LattimeChandrikha ChandrasekharanAndrew BellizziLaura HerringLee GravesBenjamin DarbroZiqiang YuanSteven LibuttiDawn Quelle
- Resource Type
- Abstract
- Publication Details
- Endocrine Abstracts
- DOI
- 10.1530/endoabs.89.B8
- ISSN
- 1479-6848
- eISSN
- 1479-6848
- Language
- English
- Date published
- 02/01/2023
- Academic Unit
- Stead Family Department of Pediatrics; Neuroscience and Pharmacology; Hematology, Oncology, and Blood & Marrow Transplantation; Biostatistics; Pathology; Internal Medicine; Radiology; Medical Genetics and Genomics
- Record Identifier
- 9984413080702771
Abstract
CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors
Endocrine Abstracts
02/01/2023
DOI: 10.1530/endoabs.89.B8
Details
Metrics
13 Record Views